Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial
Titel:
Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial
Auteur:
Stein, Eytan M Fathi, Amir T DiNardo, Courtney D Pollyea, Daniel A Roboz, Gail J Collins, Robert Sekeres, Mikkael A Stone, Richard M Attar, Eyal C Frattini, Mark G Tosolini, Alessandra Xu, Qiang See, Wendy L MacBeth, Kyle J de Botton, Stéphane Tallman, Martin S Kantarjian, Hagop M